Anti-cancer Drugs Market 2027 By Therapy, Application, and Geography | The Insight Partners

Anti-cancer Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy); Application (Leukaemia, Breast Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Skin Cancer, Others), and Geography

Report Code: TIPRE00016842 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Anti-cancer drugs are used to destroy, shrink, kill, or slow down cancerous cells' growth. The drugs are designed in a way to provide treatment through chemicals, hormones, molecular elements. The drugs are only available through prescriptions and are given under observations.

MARKET DYNAMICS

The anti-cancer drugs market growth is anticipated to grow due to increasing incidences of cancers, growing product innovations for biopharmaceuticals, and growing investments for research and developments of anti-cancer drugs. The growing precision medicine segment for cancer treatment are likely to grow growth opportunities for the market.

MARKET SCOPE

The "Anti-cancer Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-cancer drugs market with detailed market segmentation by therapy, and application. The anti-cancer drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anti-cancer drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The anti-cancer drugs market is segmented on the basis of, therapy, and application. Based on therapy, the market is divided into chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. And based on application, the market is classified as leukaemia, breast cancer, gastrointestinal cancer, respiratory/lung cancer, skin cancer, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anti-cancer drugs market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-cancer drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anti-cancer drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-cancer drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the anti-cancer drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti-cancer drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-cancer drugs in the global market. Below mentioned is the list of few companies engaged in the anti-cancer drugs market.

The report also includes the profiles of key players in anti-cancer drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AstraZeneca
  •  Merck and Co. Inc.
  •  Novartis AG
  •  AbbVie Inc.
  •  Sanofi
  •  Amgen Inc.
  •  Pfizer, Inc.
  •  F. Hoffmann-La Roche Ltd
  •  GlaxoSmithKline PLC
  •  Boehringer Ingelheim International GmbH

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-cancer Drugs Market - By Therapy
1.3.2 Anti-cancer Drugs Market - By Application
1.3.3 Anti-cancer Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI-CANCER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Middle East and Africa - Pest Analysis
4.2.4 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI-CANCER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTI-CANCER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-CANCER DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTI-CANCER DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTI-CANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. CHEMOTHERAPY
7.3.1. Overview
7.3.2. Chemotherapy Market Forecast and Analysis
7.4. TARGETED THERAPY
7.4.1. Overview
7.4.2. Targeted Therapy Market Forecast and Analysis
7.5. IMMUNOTHERAPY
7.5.1. Overview
7.5.2. Immunotherapy Market Forecast and Analysis
7.6. HORMONAL THERAPY
7.6.1. Overview
7.6.2. Hormonal Therapy Market Forecast and Analysis
8. ANTI-CANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. LEUKAEMIA
8.3.1. Overview
8.3.2. Leukaemia Market Forecast and Analysis
8.4. BREAST CANCER
8.4.1. Overview
8.4.2. Breast Cancer Market Forecast and Analysis
8.5. GASTROINTESTINAL CANCER
8.5.1. Overview
8.5.2. Gastrointestinal Cancer Market Forecast and Analysis
8.6. RESPIRATORY/LUNG CANCER
8.6.1. Overview
8.6.2. Respiratory/Lung Cancer Market Forecast and Analysis
8.7. SKIN CANCER
8.7.1. Overview
8.7.2. Skin Cancer Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. ANTI-CANCER DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Anti-cancer Drugs Market Overview
9.1.2 North America Anti-cancer Drugs Market Forecasts and Analysis
9.1.3 North America Anti-cancer Drugs Market Forecasts and Analysis - By Therapy
9.1.4 North America Anti-cancer Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Anti-cancer Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Anti-cancer Drugs Market
9.1.5.1.1 United States Anti-cancer Drugs Market by Therapy
9.1.5.1.2 United States Anti-cancer Drugs Market by Application
9.1.5.2 Canada Anti-cancer Drugs Market
9.1.5.2.1 Canada Anti-cancer Drugs Market by Therapy
9.1.5.2.2 Canada Anti-cancer Drugs Market by Application
9.1.5.3 Mexico Anti-cancer Drugs Market
9.1.5.3.1 Mexico Anti-cancer Drugs Market by Therapy
9.1.5.3.2 Mexico Anti-cancer Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Anti-cancer Drugs Market Overview
9.2.2 Europe Anti-cancer Drugs Market Forecasts and Analysis
9.2.3 Europe Anti-cancer Drugs Market Forecasts and Analysis - By Therapy
9.2.4 Europe Anti-cancer Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Anti-cancer Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anti-cancer Drugs Market
9.2.5.1.1 Germany Anti-cancer Drugs Market by Therapy
9.2.5.1.2 Germany Anti-cancer Drugs Market by Application
9.2.5.2 France Anti-cancer Drugs Market
9.2.5.2.1 France Anti-cancer Drugs Market by Therapy
9.2.5.2.2 France Anti-cancer Drugs Market by Application
9.2.5.3 Italy Anti-cancer Drugs Market
9.2.5.3.1 Italy Anti-cancer Drugs Market by Therapy
9.2.5.3.2 Italy Anti-cancer Drugs Market by Application
9.2.5.4 Spain Anti-cancer Drugs Market
9.2.5.4.1 Spain Anti-cancer Drugs Market by Therapy
9.2.5.4.2 Spain Anti-cancer Drugs Market by Application
9.2.5.5 United Kingdom Anti-cancer Drugs Market
9.2.5.5.1 United Kingdom Anti-cancer Drugs Market by Therapy
9.2.5.5.2 United Kingdom Anti-cancer Drugs Market by Application
9.2.5.6 Rest of Europe Anti-cancer Drugs Market
9.2.5.6.1 Rest of Europe Anti-cancer Drugs Market by Therapy
9.2.5.6.2 Rest of Europe Anti-cancer Drugs Market by Application
9.3. MIDDLE EAST AND AFRICA
9.3.1 Middle East and Africa Anti-cancer Drugs Market Overview
9.3.2 Middle East and Africa Anti-cancer Drugs Market Forecasts and Analysis
9.3.3 Middle East and Africa Anti-cancer Drugs Market Forecasts and Analysis - By Therapy
9.3.4 Middle East and Africa Anti-cancer Drugs Market Forecasts and Analysis - By Application
9.3.5 Middle East and Africa Anti-cancer Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 South Africa Anti-cancer Drugs Market
9.3.5.1.1 South Africa Anti-cancer Drugs Market by Therapy
9.3.5.1.2 South Africa Anti-cancer Drugs Market by Application
9.3.5.2 Saudi Arabia Anti-cancer Drugs Market
9.3.5.2.1 Saudi Arabia Anti-cancer Drugs Market by Therapy
9.3.5.2.2 Saudi Arabia Anti-cancer Drugs Market by Application
9.3.5.3 U.A.E Anti-cancer Drugs Market
9.3.5.3.1 U.A.E Anti-cancer Drugs Market by Therapy
9.3.5.3.2 U.A.E Anti-cancer Drugs Market by Application
9.3.5.4 Rest of Middle East and Africa Anti-cancer Drugs Market
9.3.5.4.1 Rest of Middle East and Africa Anti-cancer Drugs Market by Therapy
9.3.5.4.2 Rest of Middle East and Africa Anti-cancer Drugs Market by Application
9.4. SOUTH AND CENTRAL AMERICA
9.4.1 South and Central America Anti-cancer Drugs Market Overview
9.4.2 South and Central America Anti-cancer Drugs Market Forecasts and Analysis
9.4.3 South and Central America Anti-cancer Drugs Market Forecasts and Analysis - By Therapy
9.4.4 South and Central America Anti-cancer Drugs Market Forecasts and Analysis - By Application
9.4.5 South and Central America Anti-cancer Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 Brazil Anti-cancer Drugs Market
9.4.5.1.1 Brazil Anti-cancer Drugs Market by Therapy
9.4.5.1.2 Brazil Anti-cancer Drugs Market by Application
9.4.5.2 Argentina Anti-cancer Drugs Market
9.4.5.2.1 Argentina Anti-cancer Drugs Market by Therapy
9.4.5.2.2 Argentina Anti-cancer Drugs Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTI-CANCER DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTI-CANCER DRUGS MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MERCK AND CO. INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABBVIE INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SANOFI
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. AMGEN INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. F. HOFFMANN-LA ROCHE LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GLAXOSMITHKLINE PLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca
2. Merck and Co. Inc.
3. Novartis AG
4. AbbVie Inc.
5. Sanofi
6. Amgen Inc.
7. Pfizer, Inc.
8. F. Hoffmann-La Roche Ltd
9. GlaxoSmithKline PLC
10. Boehringer Ingelheim International GmbH
TIPRE00016842
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking